Santos Castañeda Selected Research

Hyperplasia

3/2022

Advances in the Treatment of Giant Cell Arteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Santos Castañeda Research Topics

Disease

46	Rheumatoid Arthritis 02/2024 - 05/2008
27	Giant Cell Arteritis (Horton Disease) 07/2023 - 07/2009
21	Vasculitis (Vasculitides) 11/2023 - 01/2011
17	Arthritis (Polyarthritis) 06/2022 - 01/2010
13	Inflammation (Inflammations) 01/2023 - 12/2011
12	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2023 - 08/2015
10	Osteoporosis 11/2022 - 01/2008
9	Autoimmune Diseases (Autoimmune Disease) 03/2023 - 06/2012
8	Atherosclerosis 01/2022 - 01/2012
7	Osteoarthritis 01/2023 - 02/2007
6	COVID-19 01/2024 - 01/2020
6	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2024 - 06/2012
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2023 - 05/2008
6	Cardiovascular Diseases (Cardiovascular Disease) 05/2019 - 12/2011
6	Purpura 03/2018 - 05/2014
5	Infections 02/2024 - 06/2014
5	Psoriatic Arthritis 01/2024 - 11/2014
5	Behcet Syndrome (Behcet's Syndrome) 01/2023 - 01/2014
5	Axial Spondyloarthritis 12/2022 - 01/2020
5	Systemic Scleroderma (Systemic Sclerosis) 03/2022 - 06/2012
5	Uveitis 01/2022 - 12/2019
5	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2022 - 01/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 11/2016
4	Ankylosing Spondylitis 01/2023 - 01/2021
4	Rheumatic Diseases (Rheumatism) 01/2021 - 01/2010
4	Takayasu Arteritis (Arteritis, Takayasu's) 01/2021 - 05/2016
4	Adult-Onset Still's Disease 01/2019 - 06/2014
3	Idiopathic Pulmonary Fibrosis 01/2023 - 08/2021
3	Obesity 05/2022 - 11/2020
3	Scleritis (Episcleritis) 01/2022 - 05/2016
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2019
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 08/2015
3	Antisynthetase syndrome 11/2019 - 08/2015
3	Fever (Fevers) 05/2016 - 06/2014
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2023 - 07/2020
2	Disease Susceptibility (Diathesis) 01/2023 - 04/2015
2	Pain (Aches) 01/2023 - 01/2017
2	Neoplasms (Cancer) 11/2022 - 08/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2019
2	Dermatomyositis (Dermatopolymyositis) 01/2022 - 07/2020
2	Corneal Ulcer 01/2022 - 01/2020
2	Joint Diseases (Joint Disease) 12/2021 - 01/2011
2	Necrosis 01/2019 - 01/2018
2	Knee Osteoarthritis 01/2017 - 02/2007
2	Lymphadenopathy 09/2015 - 06/2014

Drug/Important Bio-Agent (IBA)

19	tocilizumab (atlizumab)FDA Link 07/2023 - 05/2014
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
11	Immunoglobulin A (IgA)IBA 08/2023 - 11/2017
10	GlucocorticoidsIBA 01/2024 - 01/2008
7	AntibodiesIBA 01/2024 - 01/2013
7	Abatacept (Orencia)FDA Link 09/2023 - 03/2012
7	CytokinesIBA 01/2023 - 01/2018
7	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2011
7	C-Reactive ProteinIBA 01/2023 - 07/2010
7	Anti-Citrullinated Protein AntibodiesIBA 01/2020 - 05/2008
6	AutoantibodiesIBA 03/2023 - 02/2017
5	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 03/2012
5	Estrogens (Estrogen)FDA Link 01/2023 - 01/2009
5	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2018
5	HLA-B Antigens (HLA-B)IBA 03/2021 - 01/2014
5	Rheumatoid FactorIBA 01/2021 - 01/2017
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2008
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 01/2015
4	Ligases (Synthetase)IBA 03/2022 - 11/2019
4	Antirheumatic Agents (DMARD)IBA 01/2022 - 07/2013
3	Infliximab (Remicade)FDA Link 01/2023 - 12/2019
3	Adalimumab (Humira)FDA Link 01/2023 - 12/2019
3	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 07/2013
3	Galectin 1 (LGALS1)IBA 10/2022 - 10/2020
3	AdipokinesIBA 05/2022 - 11/2016
3	Methylprednisolone FDA LinkGeneric 01/2022 - 09/2013
3	Interleukin-33IBA 01/2021 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2012
3	InterleukinsIBA 03/2020 - 01/2011
3	Rituximab (Mabthera)FDA Link 09/2019 - 07/2018
3	Glucosamine (Dona)IBA 01/2017 - 02/2007
2	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 05/2019
2	Leflunomide (Arava)FDA LinkGeneric 01/2024 - 01/2022
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 11/2014
2	Interferon-gamma (Interferon, gamma)IBA 01/2023 - 01/2012
2	HLA-DRB1*04:01 antigenIBA 01/2023 - 03/2021
2	AdiponectinIBA 05/2022 - 11/2016
2	N 30IBA 01/2022 - 09/2020
2	Certolizumab Pegol FDA Link 01/2022 - 01/2021
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022 - 10/2017
2	Diphosphonates (Bisphosphonates)IBA 01/2022 - 01/2016
2	sarilumabIBA 12/2021 - 12/2021
2	cyclic citrullinated peptideIBA 01/2021 - 01/2013
2	Lipoproteins (Lipoprotein)IBA 11/2020 - 05/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 04/2015
2	P-SelectinIBA 01/2020 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019 - 11/2014
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2018 - 09/2015
2	Protein Tyrosine PhosphatasesIBA 01/2017 - 10/2015
2	CSK Tyrosine-Protein KinaseIBA 01/2017 - 10/2015
2	OsteoprotegerinIBA 11/2016 - 01/2014
2	Interferon Regulatory FactorsIBA 07/2014 - 05/2008

Therapy/Procedure

27	Therapeutics 11/2023 - 06/2014
10	Biological Therapy 01/2023 - 05/2017